MIRA Pharmaceuticals
Curated by SignalDeveloper of cannabinoid-based therapeutics for chronic pain and anxiety
Overview
Developer of cannabinoid-based therapeutics for chronic pain and anxiety. It offers therapeutics that targets the CB1 and 2 receptors for the treatment of phobias, social anxiety disorder, PTSD, generalized anxiety disorder, and panic disorder.
Key facts
- Founded
- 2020
- Headquarters
- Baltimore, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 2 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view